Having trouble accessing articles? Reset your cache.

Avastin U.S. sales dip

Roche (SIX:ROG; OTCQX:RHHBY) said in its 3Q10 earnings that U.S. sales of Avastin bevacizumab fell 3% on a local

Read the full 198 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE